Zelboraf Approved for Use in Erdheim-Chester Disease

Share this content:
Zelboraf Approved for Use in Erdheim-Chester Disease
Zelboraf Approved for Use in Erdheim-Chester Disease

WEDNESDAY, Nov. 8, 2017 (HealthDay News) -- Zelboraf (vemurafenib) has been approved by the U.S. Food and Drug Administration as the first drug to treat certain adults patients with Erdheim-Chester disease (ECD).

The efficacy of Zelboraf, a kinase inhibitor, was studied in 22 patients with BRAF-V600-mutation positive ECD. Fifty percent (11 patients) experienced a partial response and 4.5 percent (1 patient) experienced a complete response.

The most common side effects include arthralgia, rash, alopecia, fatigue, prolonged QT interval, and papilloma, the FDA said in a news release. Less common but more severe adverse reactions could include development of other cancers, severe skin reactions, hepatotoxicity, and kidney failure. The drug is contraindicated for pregnant women because it could harm a developing fetus, the FDA said.

"This product was first approved in 2011 to treat certain patients with melanoma that harbor the BRAF V600E mutation, and we are now bringing the therapy to patients with a rare cancer with no approved therapies," Richard Pazdur, M.D., director of the FDA's Oncology Center of Excellence, said in a statement.

The drug is produced by the Swiss pharmaceutical firm Hoffman-LaRoche.

More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Study Provides Estimates of U.S. Prevalence of Type 1, 2 Diabetes

Study Provides Estimates of U.S. Prevalence of Type ...

Prevalence of type 1 diabetes 0.5 percent, type 2 diabetes 8.5 percent among U.S. adults

Black Individuals at Highest Risk of Legal Intervention Injury

Black Individuals at Highest Risk of Legal Intervention ...

Increase in rates of injuries from 2005 to 2009, followed by a drop to 2015, returning to ~2005 levels

Research Links Doctor Burnout to Patient Safety Incidents

Research Links Doctor Burnout to Patient Safety Incidents

Physician burnout linked to increased risk of patient safety incidents, reduced patient satisfaction

is free, fast, and customized just for you!




Already a member?

Sign In Now »